Donor kir3dl1/receptor hla-bw4-80i combination reduces acute leukemia relapse after umbilical cord blood transplantation without in vitro t-cell depletion

Conclusions: Our data suggest that the donor KIR3DL1/receptor and HLA-Bw4-80I combination in UCBT results in stronger graft-versus-leukemia effects and improved outcomes in patients with acute leukemia.

Source: Mediterranean Journal of Hematology and Infectious Diseases - December 31, 2020 Category: Hematology Authors: xinchen fang, Xiaoyu zhu, Baolin Tang, Kaidi Song, Kaidi Song, Wen Yao, Xiang Wan, Huilan Liu, Zimin Sun, Jun Peng Source Type: research